Efficacy of BGJ398, a fibroblast growth factor receptor (FGFR) 1-3 inhibitor, in patients (pts) with previously treated advanced/metastatic urothelial carcinoma (mUC) with FGFR3 alterations Meeting Abstract

  

Authors:	Pal, S. K.; Rosenberg, J. E.; Keam, B.; Wolf, J.; Berger, R.; Dittrich, C.; Hoffman-Censits, J. H.; Quinn, D.; van der Noll, R.; Burris, H. A.; Galsky, M. D.; Gravis, G.; Lee, J. L.; Medioni, J.; Mortazavi, A.; Maroto, P.; Parker, K.; Chen, X.; Isaacs, R.; Bajorin, D. F.
Abstract Title:	Efficacy of BGJ398, a fibroblast growth factor receptor (FGFR) 1-3 inhibitor, in patients (pts) with previously treated advanced/metastatic urothelial carcinoma (mUC) with FGFR3 alterations
Meeting Title:	52nd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title:	Journal of Clinical Oncology
Volume:	34
Issue:	15 Suppl.
Meeting Dates:	2016 Jun 3-7
Meeting Location:	Chicago, IL
ISSN:	0732-183X
Publisher:	American Society of Clinical Oncology
Date Published:	2016-05-20
Start Page:	248s
Language:	English
ACCESSION:	WOS:000404665407090
DOI:	10.1200/JCO.2016.34.15_suppl.4517
PROVIDER:	wos
Notes:	Meeting Abstract: 4517 -- Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/155053